Next-Gen Bio-Therapeutics

Conjugated Linoleic Acid For Digestive & Metabolic Health

Pioneering clinical nutrition through advanced lipid technologies, targeted delivery systems, and metabolic optimization in partnership with the Chinese Academy of Sciences.

Featured Metabolic & Digestive Health Solutions

CLA-Enhanced Amino Acid PKU Formula for Ages 10+

CLA-Enhanced Amino Acid Formula for Ages 10+ | Digestive & Metabolic Support | China Factory

View Product Details →

CLA-Infused Metabolic Amino Acid Formula

CLA-Infused Amino Acid Metabolic Formula for Ages 10+ | Digestive Health | China Suppliers

View Product Details →

CLA-Optimized Pediatric Metabolic Formula (0-12 Months) | Gentle Digestive Support | China Factory

View Product Details →

Bio-Active CLA Amino Acid Formula for Ages 10+ | Metabolic Optimization | China Quality

View Product Details →

The Evolution of Conjugated Linoleic Acid (CLA) in Modern Biopharmaceutics

Conjugated Linoleic Acid (CLA), a naturally occurring polyunsaturated fatty acid predominantly found in ruminant meat and dairy products, has transitioned from a basic sports nutrition supplement to a cornerstone of clinical metabolism and digestive therapy. In the global industrial landscape, CLA is recognized as a vital functional lipid. The commercialization of CLA is primarily driven by its two main active isomers: cis-9, trans-11 (c9, t11) and trans-10, cis-12 (t10, c12). Each isomer targets distinct physiological pathways within the human body, facilitating dual benefits in lipid management and gut mucosal barrier integrity.

🧬

Metabolic Acceleration

Upregulates AMPK pathways, enhancing mitochondrial beta-oxidation and reducing systemic lipid accumulation in visceral adipose tissue.

🛡️

Digestive Barrier Support

Reinforces tight junction proteins (Claudin-1 and Occludin) in the gut, mitigating systemic endotoxemia and localized bowel inflammation.

🌐

Microbiome Synergy

Acts as a modulator of short-chain fatty acid (SCFA) producing bacteria, supporting gut microbial homeostasis and preventing dysbiosis.

Industrial manufacturing of high-purity CLA involves sophisticated catalytic isomerization of linoleic acid derived from natural safflower oil. The current market trend emphasizes the integration of microencapsulated CLA powders and nano-emulsified liquid formulas into Foods for Special Medical Purposes (FSMP). This ensures optimal bioavailability, stability against oxidation, and seamless incorporation into clinical diets. As global health sectors face an unprecedented rise in metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and inflammatory bowel conditions, the demand for clinically validated, bio-active lipids like CLA has surged exponentially.

Scientific Mechanisms: The Gut-Metabolic Axis

Clinically Proven PPAR-Alpha Activation

How CLA Modulates Metabolic Pathways

Conjugated Linoleic Acid operates as a potent ligand for Peroxisome Proliferator-Activated Receptors (PPARs). By activating PPAR-alpha, CLA promotes the expression of genes involved in fatty acid transport and combustion. Simultaneously, the t10, c12 isomer downregulates lipogenic enzymes, such as stearoyl-CoA desaturase-1 (SCD1), effectively preventing the storage of excess triglycerides in liver and muscle tissue. This dual-action mechanism is vital for patients struggling with insulin resistance, chronic obesity, and hepatic lipid overload.

Gut Mucosa TJ Protein Synthesis

Upholding Digestive Integrity

On the digestive front, CLA has demonstrated remarkable efficacy in mitigating gut permeability (often referred to as 'leaky gut'). Clinical studies indicate that CLA supplementation significantly reduces the production of pro-inflammatory cytokines (such as TNF-alpha and IL-6) within the lamina propria. By suppressing these inflammatory cascades, CLA preserves the structural integrity of the intestinal epithelium, preventing harmful lipopolysaccharides (LPS) from translocating into the bloodstream and triggering systemic low-grade inflammation.

I. Core Products and Business Operations

Zhongen (Tianjin) Medical Technology Co., Ltd. (SINOFNHealth) specializes in four major product lines: foods for special medical purposes (FSMP), special dietary foods, professional sports nutrition products, and staple foods for specific patient groups. Leveraging our proprietary technologies and research into functional lipids like Conjugated Linoleic Acid, we develop a diverse range of health and nutritional products, detailed below:

(1) Main Food Series for Special Patients

Low-protein category: Low-protein rice, flour, noodles, and low-protein boxed meals are produced using patented biological protein removal technology. Genuine rice is processed through non-starch compression to achieve significantly lower protein content compared to conventional staple foods. This category is primarily targeted at individuals with phenylketonuria (PKU) or chronic kidney disease (CKD), where metabolic management is critical.
Specialized low-phosphorus whey protein for CKD: High-purity isolated whey protein with a low-phosphorus formulation, tailored for nutritional intervention in patients with renal disease.

(II) Special Dietary Foods

Covering eight major product categories for the entire population, featuring multiple star products developed using specialized patented technologies, with a strong focus on metabolic and digestive health optimization:

Weight management: Categorized into blockade-based, meal replacement, metabolism-promoting, and fat-burning types. Each incorporates four core technologies: dual inhibition of sugar and fat metabolism, sustained satiety release, AMP-mediated metabolic acceleration (enhanced by CLA isomers), and enhanced fat oxidation.
Beauty Care Series: Anti-aging, brightening, hydration, and anti-hair loss formulations, complemented by free radical scavenging, melanin inhibition, hyaluronic acid hydration, and four-dimensional cell activation technology.
Women's Health: Series on Qi and Blood Regulation, Uterine Nourishment, Intimate Care, and Endocrine Balance.
Male Health: Series including kidney tonification and foundation consolidation, liver protection and alcohol detoxification, energy enhancement, prostate care, uric acid regulation, and metabolic regulation.
Children's Nutrition Series: Immune Protection, Cognitive Development, Intestinal Health (focusing on prebiotic and lipid synergy), Vision Protection, Bone Development, and Appetite Improvement.
Health for Middle-aged and Elderly: Management of the Three Highs (hypertension, hyperlipidemia, hyperglycemia), bone and joint health, cognitive function, cardiac care, and eye health series.
Other star products include: Qi & Blood Formula, ketogenic fat-loss products, Freisu, Niu Pi Peptide 13-Peptide Complex Drink, sleep aids, and 3D calcium supplementation products.

(3) Professional Sports Nutrition Foods (Shaping Master Series)

Included in the national procurement catalog, featuring energy gels, whey protein powder, branched-chain amino acid peptide powder, Joint Guardian, composite vitamin/mineral powder, and glutamine peptide powder. This series covers all aspects of sports performance—including energy supply, muscle growth, joint protection, and recovery—with zero doping content, often incorporating CLA to support lean muscle retention and fat metabolism.

(4) Foods for Special Medical Purposes (FSMP)

They are categorized into three main types: complete nutritional formulas, formulations for specific diseases, and component nutritional supplements, with two core flagship products:

En Full Power: China's first comprehensive nutritional formula with a high energy density of 1.5 kcal/ml. It is lactose-free, fragrance-free, low in residue, and designed to support metabolic stability in critically ill patients.
Enli'an: A residue-free, fully nutritious formula liquid with low osmotic pressure and nano-emulsion technology, tailored for gastrointestinal-related diagnostic, therapeutic, and digestive recovery applications.

Core Business Summary

Relying on the scientific research platform of the Chinese Academy of Sciences, the company integrates R&D, production, and sales, focusing on four key sectors: specialized medical nutrition, therapeutic diets, patient staple foods, and sports nutrition. It provides comprehensive solutions including disease-specific nutritional interventions, daily health maintenance, and sports nutrition support.

II. Target Market and Application Scenarios

(1) Target Market

Our products serve a diverse and highly demanding global market, spanning clinical patients to active lifestyle consumers:

Target patient population: Children with phenylketonuria, patients with chronic kidney disease/blood dialysis, individuals with gastrointestinal disorders requiring mucosal repair, individuals undergoing preoperative or postoperative care, severe malnutrition cases, and patients with hepatic or renal insufficiency.
The mass health consumption market:
- General adults: Individuals with needs such as weight management, anti-aging beauty care, liver protection during late-night social engagements, endocrine regulation, and uric acid control.
- Female population: Individuals with qi and blood deficiency, menstrual discomfort, ovarian health concerns, or private health issues.
- Child population: School-aged and preschool children with weakened immunity, picky eating or anorexia, gastrointestinal disorders, visual fatigue, delayed growth in height, or poor concentration.
- Middle-aged and elderly population: Individuals with hypertension, hyperlipidemia, hyperglycemia; osteoporosis; joint discomfort; memory decline; or cardiac and retinal health issues.
Professional Sports Market: Professional athletes, national sports teams, fitness enthusiasts, and partners in professional sporting events.
Institutional distribution network: Comprising 204 tertiary hospitals, medical institutions, and professional channels involving nutritionists/physicians nationwide.

(II) Application Scenarios

Our formulations are designed to integrate seamlessly into clinical protocols and daily wellness routines:

Medical clinical scenarios: Daily dietary interventions for nephropathy and genetic disorders; intestinal preparation before and after gastrointestinal/perianal surgeries or endoscopic procedures; nutritional support for hospitalized patients, bedridden individuals, or those with inadequate intake; routinely utilized by hospital clinical nutrition departments and dialysis centers.
Daily Home Care: Comprehensive nutritional supplementation for the entire family, long-term management of chronic diseases, child growth support, health maintenance for middle-aged and elderly individuals, menstrual/postpartum care for women, and daily liver and kidney protection for men.
Body shaping solutions: Fat reduction with calorie control, healthy body contouring, anti-aging and skin brightening, hydration therapy, hair loss prevention, and hair care.
Sports competition scenarios: Energy replenishment for professional training and competition participation, muscle building, post-exercise recovery, and joint protection.
Social occasions: Liver protection and alcohol detoxification before and after business drinking; energy replenishment for individuals who stay up late.

III. Technical Advantages and Local Adaptability

(1) Core Technological Advantages

Top-tier R&D Platform: Jointly established collaborative laboratories/research centers with four major institutes of the Chinese Academy of Sciences, featuring a postdoctoral research workstation, the National Edible Enzyme Functional Research Center, and a sub-center of the National Engineering Laboratory. Applications have been submitted for recognition as a CNAS National Laboratory.
Core Patent Technology:
- Biological protein removal technology: With two national invention patents held exclusively by only two companies worldwide, it enables complete protein removal from whole rice grains, breaking the technological monopoly of foreign manufacturers.
- Functional formulation technologies: Dual blockade of sugar and oil metabolism, acceleration of AMP metabolism, free radical scavenging, activation of hematopoietic stem cells, Tongdun immune activation, and dozens of other specialized formulation technologies.
- Formulation processes: Advanced techniques such as nano-emulsions, nanotargeted delivery, SFE-Tech plant extraction, and small-molecule peptide extraction are employed to enhance absorption efficiency.
Research Team: A full-time R&D team composed of a Ph.D. in Medical Nutrition from Peking University, a postdoctoral researcher at the Chinese Academy of Sciences, and senior overseas R&D experts, who are involved throughout the entire process including formula development, efficacy validation, and clinical trials.
Production and Quality Control: Operating a modern smart manufacturing facility spanning 80 mu (approximately 5.3 hectares), the company holds certifications under the three major standards—ISO 22000, ISO 9001, and HACCP—and produces specialized dietary products in compliance with special medical food regulations.
Clinical validation: Multiple products have undergone clinical trials at tertiary hospitals including Peking University Third Hospital, with safety and efficacy confirmed through clinical implementation in 204 tertiary hospitals.

(II) Local Adaptability

Regional Industry Alignment: The company is located in the Tianjin Port Free Trade Zone and Tianjin Airport Economic Zone, leveraging regional industrial strengths, logistics advantages, and policy support to achieve large-scale production and nationwide distribution capabilities.
Adaptation to Population Needs:
- For prevalent genetic metabolic disorders and chronic kidney disease (with approximately 120 million patients in China), specialized low-protein and low-phosphorus products are designed to meet the dietary needs of local patients.
- Developed based on the characteristics of Chinese cuisine, these staple food products differ from overseas starch-based alternatives and offer a taste profile better aligned with Chinese dietary preferences.
Market Compliance: Fully compliant with China's national regulatory standards for special medical and dietary foods, possessing comprehensive registration qualifications for all categories of special medical products, as well as certifications as a high-tech enterprise and a specialized, refined, innovative enterprise, thereby meeting domestic regulatory requirements.
Channel Adaptation: We have strengthened our presence in domestic hospital channels, established deep partnerships with top-tier local hospitals, and tailored our offerings to align with China's healthcare system and consumer market landscape.

IV. Company Background and Contact Information

(I) Company Background

Zhongen (Tianjin) Medical Technology Co., Ltd. (SINOFNHealth) is a subsidiary of the Chinese Academy of Sciences and the only company under its umbrella specializing in the field of specialized medical nutrition and dietary solutions.

With 13 years of industry expertise and a total investment of RMB 350 million, the company has established a modern intelligent manufacturing base spanning 80 mu (approximately 13 hectares). It holds 89 intellectual property rights, possesses over 1,500 mature formulations, launches more than 100 new products annually, has completed 12 key technological projects, and published numerous journal papers.

Qualifications & Industry Position

We are recognized as a High-tech Enterprise, a Specialized, Refined, Unique and Innovative Enterprise, and a Postdoctoral Research Workstation. Our facility is certified under the three major management systems: ISO 9001 Quality Management System, ISO 22000 Food Safety Management System, and HACCP Hazard Analysis and Critical Control Points System.

Furthermore, we are a registered supplier of nutritional products for the General Administration of Sport of China, a partner for centralized procurement of nutritional supplements by national teams, and have broken Japan's technological monopoly in the field of low-protein staple foods.